|
2024
|
Invention
|
Aryl-or heteroaryl-substituted benzene compounds.
The present invention relates to aryl- or hete... |
|
|
Invention
|
Combination therapy for treating cancer.
The disclosure relates to methods, compounds for use an... |
|
2023
|
Invention
|
Ezh2 inhibitors for treating cancer.
The present disclosure relates to compositions comprising i... |
|
|
Invention
|
Arginine methyltransferase inhibitors and uses thereof.
Described herein are compounds of Formul... |
|
|
Invention
|
Combination therapy for treating cancer.
The present disclosure relates to compositions comprisi... |
|
|
Invention
|
Crystalline compounds and methods of making the same.
Provided herein are methods for making a c... |
|
|
Invention
|
Methods of using ehmt2 inhibitors in immunotherapies.
The present disclosure relates to methods ... |
|
|
Invention
|
Use of ezh2 inhibitors for treating cancer.
The disclosure provides a method for treating cancer... |
|
|
Invention
|
Methods of using ehmt2 inhibitors in treating or preventing blood disorders.
The present disclos... |
|
|
Invention
|
Substituted benzene compounds.
The present invention relates to substituted benzene compounds. T... |
|
|
Invention
|
Ezh2 inhibitors for treating lymphoma.
The present invention relates to compositions comprising ... |
|
|
Invention
|
Combination therapy for treating cancer.
The present disclosure relates to methods of a malignan... |
|
|
Invention
|
Method for treating cancer.
The present disclosure relates to pharmaceutical compositions compri... |
|
|
Invention
|
Combination therapies with ehmt2 inhibitors.
The present disclosure relates to a method of preve... |
|
|
Invention
|
Myst family histone acetyltransferase inhibitors.
The present disclosure provides compounds, pha... |
|
|
Invention
|
Use of ezh2 inhibitors for treating cancer.
The disclosure provides methods of treating, identif... |
|
2022
|
Invention
|
Methods of synthesizing substituted purine compounds.
The present invention provides an efficien... |
|
|
Invention
|
Carm1 inhibitors and uses thereof.
Provided herein are compounds of Formula (I):
Provided here... |
|
|
Invention
|
Crystalline forms of n-((1r,3s)-3-(4-acetylpiperazin-1-yl)cyclohexyl)-4-fluoro-7-methyl-1h-indole... |
|
|
Invention
|
Salt form of a human histone methyltransferase ezh2 inhibitor.
Provided herein is N-((4,6-dimeth... |
|
|
Invention
|
Inhibition of smarca2 for treatment of cancer.
The present disclosure provides treatment modalit... |
|
|
Invention
|
Combination therapies with setd2 inhibitors.
The present disclosure provides SETD2 protein inhib... |
|
|
Invention
|
Combination therapies with setd2 inhibitors. The present disclosure provides SETD2 protein inhibi... |
|
|
Invention
|
Combination therapy for treating cancer.
The present invention relates to compositions comprisin... |
|
|
Invention
|
Amine-substituted heterocyclic compounds as ehmt2 inhibitors, salts thereof, and methods of synth... |
|
|
Invention
|
Methods of treating cancer.
The present invention relates to methods of treating cancer by admin... |
|
|
Invention
|
Crebbp related cancer therapy.
The present disclosure provides novel cancer therapies. The treat... |
|
|
G/S
|
Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products, name... |
|
|
G/S
|
Pharmaceutical products for the treatment of cancer; pharmaceutical products, namely, EZH2 inhibi... |
|
|
G/S
|
Pharmaceutical products for the treatment of cancer;
pharmaceutical products, namely, EZH2 inhib... |
|
2021
|
Invention
|
Substituted fused bi- or tri- heterocyclic compounds as ehmt2 inhibitors.
The present disclosure... |
|
|
Invention
|
Method of treating cancer.
The present invention relates to methods of treating cancer by admini... |
|
|
Invention
|
Smyd inhibitors.
The present disclosure provides carboxamides and sulfonamides having Formula (I... |
|
|
Invention
|
Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof.
The pre... |
|
|
Invention
|
Methods of using ehmt2 inhibitors.
The present disclosure relates to a method of preventing or t... |
|
|
G/S
|
pharmaceutical products for the treatment of cancer; pharmaceutical products, namely, EZH2 inhibi... |
|
|
Invention
|
Smarca4 inhibition for the treatment of cancer.
The present disclosure provides methods of deter... |
|
|
Invention
|
Use of ezh2 inhibitors for treating cancer.
The present disclosure provides methods for the trea... |
|
|
Invention
|
Setd2 inhibitors and related methods and uses, including combination therapies.
The present disc... |
|
2020
|
G/S
|
Providing financial support services for patients and caregivers, namely, providing financial ass... |
|
|
Invention
|
Carm1 inhibitors and uses thereof. Provided herein are compounds of Formula (I):
2d, are as defi... |
|
2019
|
Invention
|
Methods of treating whsc1-overexpressing cancers by inhibiting setd2.
The present disclosure pro... |
|
|
G/S
|
Pharmaceutical products for the treatment of human diseases and disorders, namely, cancer, cell p... |
|
|
G/S
|
Pharmaceutical products. |
|
|
Invention
|
Substituted indoles and methods of use thereof.
The present disclosure provides substituted indo... |
|
|
Invention
|
Pyridin-2-one compounds useful as smarca2 antagonists.
This disclosure generally relates to pyri... |
|
|
G/S
|
pharmaceutical products for the treatment of human diseases and disorders, namely, genetic diseas... |
|
|
G/S
|
pharmaceutical products for the treatment of human diseases and disorders, namely, cancer, cell p... |
|
2018
|
Invention
|
Inhibitors of ezh2 and methods of use thereof.
The disclosure provides a method of treating canc... |
|
2017
|
Invention
|
Compounds containing a sulfonic group as kat inhibitors.
The present invention provides compound... |
|
|
G/S
|
Pharmaceutical products for the prevention and treatment of
cancer; pharmaceutical products, nam... |
|
|
Invention
|
Use of ezh2 inhibitors for treating cancer. The disclosure provides a method for treating cancer ... |
|
2011
|
G/S
|
Research, discovery and development of targeted therapeutics for the treatment of genetically-def... |
|
|
G/S
|
Research, discovery and development of targeted therapeutics
for the treatment of genetically-de... |
